This event is archived. Final snapshot from when the story concluded. View on Dashboard
Events / Business / AstraZeneca China Fraud Lawsuit
Business class action lawsuit

AstraZeneca China Fraud Lawsuit

Analysis based on 9 articles · First reported Feb 07, 2025 · Last updated Feb 14, 2025

Sentiment
-50
Attention
4
Articles
9
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard
Market Impact

The class action lawsuit against AstraZeneca for alleged insurance fraud in China and the detention of its China President is expected to negatively impact AstraZeneca's stock price and business activities in China. This event highlights increased legal risks for pharmaceutical companies operating in international markets, particularly in China.

Pharmaceuticals Legal Services
Event Summary

A class action securities lawsuit has been filed against AstraZeneca by Levi & Korsinsky on behalf of investors who suffered losses between February 23, 2022, and December 17, 2024. The lawsuit alleges that AstraZeneca engaged in insurance fraud in China, leading to heightened legal exposure and the detention of its China President by Chinese law enforcement authorities. The complaint claims AstraZeneca understated its legal risks, which, once revealed, could materially harm its business activities in China. Investors have until February 21, 2025, to request to be appointed as lead plaintiff.

Key Actions
100 Levi & Korsinsky notified investors of lawsuit AstraZeneca
90 AstraZeneca understated legal risks
85 China detained President AstraZeneca
Entities Involved
stock
AstraZeneca
AstraZeneca is facing a class action securities lawsuit due to alleged insurance fraud in China and subsequent legal exposure, including the detention of its China President. This could materially harm AstraZeneca's business activities in China and has led to a negative market sentiment.
Importance 100.0 Sentiment -60.0
priv
Levi & Korsinsky
Importance 0.0 Sentiment 0.0
cnt
China
Importance 0.0 Sentiment 0.0
Relationships
AstraZeneca related ↔ China
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.